Application 021162
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | TABLET;ORAL | 12.5MG;40MG | Yes | No |
| 002 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | TABLET;ORAL | 12.5MG;80MG | Yes | No |
| 003 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | TABLET;ORAL | 25MG;80MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021162-001 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | 12.5MG;40MG | TABLET / ORAL | AB | RLD | 2000-11-17 |
| N021162-002 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 2000-11-17 |
| N021162-003 | MICARDIS HCT | HYDROCHLOROTHIAZIDE; TELMISARTAN | 25MG;80MG | TABLET / ORAL | AB | RLD, RS | 2004-04-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021162-001 | AB |
| N021162-002 | AB |
| N021162-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021162-001 | MICARDIS HCT | 12.5MG;40MG | TABLET / ORAL | AB | RLD | 2000-11-17 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021162-002 | MICARDIS HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 2000-11-17 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021162-003 | MICARDIS HCT | 25MG;80MG | TABLET / ORAL | AB | RLD, RS | 2004-04-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021162-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021162-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021162-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Micardis HCT | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | b078dae2-664d-4144-847a-3b9d9b557402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 021162 NDA021162 0597-0044 0597-0043 0597-0042 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0054-0545 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0054-0545 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | Hikma Pharmaceuticals USA Inc. | NDA AUTHORIZED GENERIC | Current |
| 0054-0545 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0054-0546 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0054-0546 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | Hikma Pharmaceuticals USA Inc. | NDA AUTHORIZED GENERIC | Current |
| 0054-0546 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0054-0547 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0054-0547 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | Hikma Pharmaceuticals USA Inc. | NDA AUTHORIZED GENERIC | Current |
| 0054-0547 | telmisartan and hydrochlorothiazide | telmisartan and hydrochlorothiazide | West-Ward Pharmaceuticals Corp. | NDA AUTHORIZED GENERIC | Current |
| 0597-0042 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0042 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0042 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0042 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0043 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0043 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0043 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0043 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0044 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0044 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0044 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0044 | Micardis HCT | telmisartan and hydrochlorothiazide | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72985 | SUPPL | 2022-12-21 |
| 72976 | SUPPL | 2022-12-21 |
| 64355 | SUPPL | 2020-08-21 |
| 64340 | SUPPL | 2020-08-21 |
| 52299 | SUPPL | 2018-02-02 |
| 52261 | SUPPL | 2018-02-02 |
| 36249 | SUPPL | 2016-01-25 |
| 26946 | SUPPL | 2016-01-14 |
| 36250 | SUPPL | 2014-12-16 |
| 26947 | SUPPL | 2014-12-15 |
| 14538 | SUPPL | 2012-11-07 |
| 4511 | SUPPL | 2012-10-26 |
| 14537 | SUPPL | 2012-01-23 |
| 14535 | SUPPL | 2012-01-23 |
| 4510 | SUPPL | 2012-01-23 |
| 4509 | SUPPL | 2012-01-23 |
| 23630 | ORIG | 2011-12-22 |
| 36248 | SUPPL | 2011-05-27 |
| 14536 | SUPPL | 2011-05-27 |
| 26945 | SUPPL | 2011-05-06 |
| 26944 | SUPPL | 2011-05-06 |
| 26943 | SUPPL | 2009-11-25 |
| 4508 | SUPPL | 2009-11-25 |
| 36247 | SUPPL | 2009-09-17 |
| 14534 | SUPPL | 2009-09-17 |
| 4507 | SUPPL | 2007-03-06 |
| 36246 | SUPPL | 2005-09-08 |
| 26942 | SUPPL | 2005-09-08 |
| 26941 | SUPPL | 2004-04-29 |
| 41996 | ORIG | 2004-03-11 |
| 36245 | ORIG | 2000-11-17 |
| 26940 | ORIG | 2000-11-17 |